Thiard News@F4F

@newsen.bsky.social

5 months ago

ESSA Pharma Completes Acquisition by XenoTherapeutics, Expanding Biotech Horizons ESSA Pharma has officially completed its acquisition by XenoTherapeutics, marking a significant milestone in the biotech industry with potential new treatments on the horizon.

ESSA Pharma Completes Acquisition by XenoTherapeutics, Expanding Biotech Horizons #United_States #biotechnology #ESSA_Pharma #South_San_Francisco #XenoTherapeutics

Thiard News@F4F

@newsen.bsky.social

6 months ago

ESSA Pharma Receives Green Light for Acquisition by XenoTherapeutics Amid Major Shareholder Approval ESSA Pharma shareholders overwhelmingly approve acquisition by XenoTherapeutics, paving the way for a new phase in biotech collaboration and innovation.

ESSA Pharma Receives Green Light for Acquisition by XenoTherapeutics Amid Major Shareholder Approval #USA #Acquisition #ESSA_Pharma #South_San_Francisco #XenoTherapeutics

Thiard News@F4F

@newsen.bsky.social

6 months ago

ESSA Pharma Inc. Shares Details on Recent Developments with Supreme Court in British Columbia ESSA Pharma Inc. provides significant updates regarding its application to the British Columbia Supreme Court, impacting its merger with XenoTherapeutics.

ESSA Pharma Inc. Shares Details on Recent Developments with Supreme Court in British Columbia #Canada #Vancouver #biotechnology #ESSA_Pharma #XenoTherapeutics

Thiard News@F4F

@newsen.bsky.social

6 months ago

ESSA Pharma Inc. Modifies Agreement with XenoTherapeutics for Strategic Transactions ESSA Pharma Inc. has amended its agreement with XenoTherapeutics, impacting shareholder returns and transaction terms, now scheduled for discussion.

ESSA Pharma Inc. Modifies Agreement with XenoTherapeutics for Strategic Transactions #ESSA_Pharma #XenoTherapeutics #XOMA_Royalty

Thiard News@F4F

@newsen.bsky.social

6 months ago

ESSA Pharma Inc. Postpones Special Meeting to September 29, 2025 for Further Discussions ESSA Pharma Inc. has announced the adjournment of its special meeting to September 29, 2025, to discuss potential revised transaction terms with XenoTherapeutics.

ESSA Pharma Inc. Postpones Special Meeting to September 29, 2025 for Further Discussions #United_States #ESSA_Pharma #South_San_Francisco #NASDAQ_EPIX #XenoTherapeutics

Thiard News@F4F

@newsen.bsky.social

7 months ago

ESSA Pharma Inc. Updates Nasdaq Due Bill Trading for Cash Distribution Clarification ESSA Pharma Inc. announced important updates regarding the Nasdaq trading related to a cash distribution of $80 million to shareholders as part of a business transition.

ESSA Pharma Inc. Updates Nasdaq Due Bill Trading for Cash Distribution Clarification #United_States #NASDAQ #ESSA_Pharma #South_San_Francisco #XenoTherapeutics

Thiard News@F4F

@newsen.bsky.social

7 months ago

ESSA Pharma Inc. Announces Important Ex-Dividend Date and Trading Procedures ESSA Pharma has revealed critical details regarding a cash distribution and ex-dividend date connected to its acquisition by XenoTherapeutics.

ESSA Pharma Inc. Announces Important Ex-Dividend Date and Trading Procedures #United_States #NASDAQ #ESSA_Pharma #South_San_Francisco #XenoTherapeutics

Thiard News@F4F

@newsen.bsky.social

8 months ago

ESSA Pharma Inc. Declares $80 Million Cash Distribution Amidst Company Transition ESSA Pharma is set to distribute $80 million to shareholders after a court ruling, marking a significant business transition as it prepares for a merger.

ESSA Pharma Inc. Declares $80 Million Cash Distribution Amidst Company Transition #United_States #ESSA_Pharma #XenoTherapeutics #US$80_Million #South_San_Francisco,_CA

Thiard News@F4F

@newsen.bsky.social

8 months ago

ESSA Pharma Inc. Seeks Interim Court Order for Shareholder Cash Distribution ESSA Pharma Inc. aims to secure court approval for a cash distribution to shareholders in connection with its upcoming business transaction.

ESSA Pharma Inc. Seeks Interim Court Order for Shareholder Cash Distribution #Canada #Vancouver #ESSA_Pharma #Supreme_Court #Xeno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

8 months ago

Halper Sadeh LLC Investigates Possible Securities Violations for Shareholders of DALN, RGLD, and EPIX Halper Sadeh LLC is probing potential federal securities violations by DallasNews, Royal Gold, and ESSA Pharma, advocating for shareholder rights.

Halper Sadeh LLC Investigates Possible Securities Violations for Shareholders of DALN, RGLD, and EPIX #New_York #US #ESSA_Pharma #Royal_Gold #DallasNews

Thiard News@F4F

@newsen.bsky.social

8 months ago

ESSA Pharma Inc. Finalizes Definitive Acquisition Agreement with XenoTherapeutics and XOMA Royalty Corporation ESSA Pharma Inc. has entered a definitive acquisition agreement with XenoTherapeutics, supported by XOMA Royalty Corporation, promising cash value to shareholders.

ESSA Pharma Inc. Finalizes Definitive Acquisition Agreement with XenoTherapeutics and XOMA Royalty Corporation #USA #ESSA_Pharma #South_San_Francisco #XenoTherapeutics #XOMA_Royalty

Thiard News@F4F

@newsen.bsky.social

11 months ago

ESSA Pharma Announces Fiscal Second Quarter Financial Results Amid Strategic Review for Maximizing Shareholder Value ESSA Pharma reported its financial results for the fiscal second quarter, revealing a shift in focus towards maximizing shareholder value through strategic options.

ESSA Pharma Announces Fiscal Second Quarter Financial Results Amid Strategic Review for Maximizing Shareholder Value #USA #ESSA_Pharma #South_San_Francisco #Prostate_Cancer #NASDAQ_EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Gross Law Firm Informs ESSA Pharma Investors About Class Action Deadline Approaching in 2025 The Gross Law Firm has announced a reminder for ESSA Pharma Inc. shareholders regarding an impending class action lawsuit with a deadline of March 25, 2025.

Gross Law Firm Informs ESSA Pharma Investors About Class Action Deadline Approaching in 2025 #USA #New_York #Class_Action #Gross_Law_Firm #ESSA_Pharma

Thiard News@F4F

@newsen.bsky.social

1 year ago

ESSA Pharma Inc. Investors Invited to Lead Securities Fraud Litigation Amid Controversy Investors in ESSA Pharma Inc. are urged to join a class action lawsuit over potential securities fraud. Key deadlines approach for filing.

ESSA Pharma Inc. Investors Invited to Lead Securities Fraud Litigation Amid Controversy #United_States #New_York #Class_Action #Securities_Fraud #ESSA_Pharma

Thiard News@F4F

@newsen.bsky.social

1 year ago

Faruqi & Faruqi Alerts ESSA Pharma Investors About Class Action Lawsuit By March 2025 Deadline Faruqi & Faruqi, LLP is notifying ESSA Pharma investors about a significant class action lawsuit. Investors must act by March 25, 2025, to participate.

Faruqi & Faruqi Alerts ESSA Pharma Investors About Class Action Lawsuit By March 2025 Deadline #USA #New_York #Class_Action #ESSA_Pharma #Faruqi_&_Faruqi

Thiard News@F4F

@newsen.bsky.social

1 year ago

Levi & Korsinsky Alerts ESSA Pharma Shareholders on Class Action Deadline Levi & Korsinsky reminds investors of ESSA Pharma Inc. about the upcoming lead plaintiff deadline in a crucial class action lawsuit regarding alleged securities fraud.

Levi & Korsinsky Alerts ESSA Pharma Shareholders on Class Action Deadline #United_States #New_York #ESSA_Pharma #Levi_Korsinsky #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Final Opportunity for EPIX Investors to Lead ESSA Pharma Securities Fraud Lawsuit EPIX investors have a crucial chance to join the class action lawsuit against ESSA Pharma. Learn how to protect your rights.

Final Opportunity for EPIX Investors to Lead ESSA Pharma Securities Fraud Lawsuit #United_States #Los_Angeles #Schall_Law_Firm #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

EPIX Securities Fraud Lawsuit: Important Deadline for Investors of ESSA Pharma Inc. A new class action lawsuit is underway against ESSA Pharma Inc. for securities fraud. EPIX investors need to act quickly to meet the March 2025 deadline.

EPIX Securities Fraud Lawsuit: Important Deadline for Investors of ESSA Pharma Inc. #United_States #New_York #Rosen_Law_Firm #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors Urged to Connect with Levi & Korsinsky for ESSA Pharma Inc. Legal Recourse Levi & Korsinsky alerts ESSA Pharma Inc. investors about a class action lawsuit, highlighting their potential rights in the matter before March 25, 2025.

Investors Urged to Connect with Levi & Korsinsky for ESSA Pharma Inc. Legal Recourse #United_States #New_York #Levi_&_Korsinsky #Securities_Fraud #ESSA_Pharma

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pomerantz Law Firm Files Class Action Against ESSA Pharma Inc. and Its Executives A class action lawsuit has been initiated against ESSA Pharma Inc. and select executives, alleging violations of federal securities laws. Investors are seeking damages for misleading statements.

Pomerantz Law Firm Files Class Action Against ESSA Pharma Inc. and Its Executives #USA #New_York #Class_Action #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

ESSA Pharma Inc. Class Action Lawsuit: Important Deadline for Shareholders to Register The Gross Law Firm is notifying ESSA Pharma Inc. shareholders about an upcoming class action lawsuit with a deadline on March 25, 2025. Learn more here.

ESSA Pharma Inc. Class Action Lawsuit: Important Deadline for Shareholders to Register #United_States #New_York #Class_Action #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors Encouraged to Join ESSA Pharma Securities Fraud Class Action Lawsuit EPIX investors are invited to participate in a class action lawsuit against ESSA Pharma Inc. over alleged securities fraud, with representation from Schall Law Firm.

Investors Encouraged to Join ESSA Pharma Securities Fraud Class Action Lawsuit #United_States #Los_Angeles #Schall_Law_Firm #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors of ESSA Pharma: Key Deadline Approaches for Class Action Lawsuit Against EPIX ESSA Pharma investors should take note of the upcoming deadline to join a class action lawsuit alleging securities fraud. Representation is available through a legal firm specializing in investor rights.

Investors of ESSA Pharma: Key Deadline Approaches for Class Action Lawsuit Against EPIX #United_States #New_York #Rosen_Law_Firm #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Levi & Korsinsky Alerts ESSA Pharma Investors About Class Action Lawsuit and Important Deadlines Important update from Levi & Korsinsky for ESSA Pharma Inc. investors regarding a class action lawsuit. Learn about eligibility and deadlines.

Levi & Korsinsky Alerts ESSA Pharma Investors About Class Action Lawsuit and Important Deadlines #USA #New_York #Levi_&_Korsinsky #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pomerantz Law Firm Initiates Class Action Against ESSA Pharma Inc. Amid Securities Violations Pomerantz LLP has filed a class action lawsuit against ESSA Pharma Inc. on behalf of investors who experienced losses. This case focuses on the alleged violations of securities laws.

Pomerantz Law Firm Initiates Class Action Against ESSA Pharma Inc. Amid Securities Violations #United_States #New_York #Class_Action #Pomerantz_LLP #ESSA_Pharma

Thiard News@F4F

@newsen.bsky.social

1 year ago

Join the Class Action Against ESSA Pharma Inc. Before March 2025 Deadline Shareholders of ESSA Pharma Inc. urged to join a class action lawsuit by March 25, 2025, due to allegedly misleading statements.

Join the Class Action Against ESSA Pharma Inc. Before March 2025 Deadline #USA #New_York #Gross_Law_Firm #ESSA_Pharma #EPIX_Class_Action

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors of ESSA Pharma Inc. urged to join securities class action lawsuit by Levi & Korsinsky Levi & Korsinsky LLP has announced a class-action lawsuit against ESSA Pharma Inc. concerning alleged securities fraud claims, targeting investors for recovery discussions.

Investors of ESSA Pharma Inc. urged to join securities class action lawsuit by Levi & Korsinsky #USA #New_York #Levi_&_Korsinsky #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

EPIX Investors Encouraged to Join Class Action Against ESSA Pharma for Alleged Fraud EPIX investors are reminded of their opportunity to lead a class action lawsuit against ESSA Pharma Inc. for alleged securities fraud violations. Quick action is advised.

EPIX Investors Encouraged to Join Class Action Against ESSA Pharma for Alleged Fraud #United_States #Los_Angeles #Schall_Law_Firm #ESSA_Pharma #EPIX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors of ESSA Pharma Inc. Urged to Participate in Class Action Lawsuit by Rosen Law Firm Rosen Law Firm encourages ESSA Pharma investors to join a class action lawsuit due to potential securities fraud. Deadline approaching soon.

Investors of ESSA Pharma Inc. Urged to Participate in Class Action Lawsuit by Rosen Law Firm #United_States #New_York #Class_Action #Rosen_Law_Firm #ESSA_Pharma

Thiard News@F4F

@newsen.bsky.social

1 year ago

ESSA Pharma Inc. Holds Annual General Meeting and Elects Board Members ESSA Pharma Inc. has successfully conducted its Annual General Meeting, re-electing board members and appointing new auditors to oversee operations.

ESSA Pharma Inc. Holds Annual General Meeting and Elects Board Members #USA #ESSA_Pharma #South_San_Francisco #Prostate_Cancer #David_Parkinson